Order Careers Contact Us Sign in Adaptive Biotechnologies Order Careers
Contact Us Sign in Immune Profiling Platform Platform OverviewPublications
Products & Services LIFE SCIENCES RESEARCHimmunoSEQ®CLINICAL
DIAGNOSTICSclonoSEQ®PipelineDRUG DISCOVERYCellular TherapyVaccines
PARTNERSHIPS Cancer Cellular TherapyAntigen MapBiopharma PartnershipsStrategic
Collaborators About Us Our StoryCultureCareersNewsroomContact Us About Us Our
Story ABOUT US Our Story We’ve spent years laying the scientific and
technological groundwork to be the experts on the adaptive immune system. With
our partners, we’ve spearheaded the discovery and development of its vast
applications across healthcare —and it’s just the beginning. OUR VISION We aim
to improve people’s lives by translating the scale and precision of their
adaptive immune systems into products to diagnose, treat, and monitor disease.
Adaptive Culture Who we are Pioneers We are a company of clever and
collaborative individuals with distinct talents and a singular vision for
translating the wisdom of the adaptive immune system with precision and at
scale. Team players We enable leaders across various disciplines—immunology,
sequencing, computational biology, and software development—to converge every
day to uncover more about the adaptive immune system. Partners We empower our
partners in the academic and biopharmaceutical communities with our platform,
products, services, and data. Together, we’re helping to advance the field of
immune-driven medicine. LEADERSHIP Uniquely equipped to achieve our bold
visionExecutivesBoard MembersExecutives Chad Robins Chief Executive Officer &
Co-founder Harlan Robins, PhD Head of Innovation & Co-founder Julie Rubinstein
President Chad Cohen Chief Financial Officer Sean Nolan Chief Technical
Officer Sharon Benzeno, PhD Senior Vice President, Adaptive Research &
Business Development Nancy Hill Senior Vice President, Operations Charles Sang
Senior Vice President, Adaptive Diagnostics Lori Stewart Vice President,
People Board Members Mike Pellini, MD Board Member Eric Dobmeier Board Member
David Goel Board Member Robert Hershberg, MD, PhD Board Member Arnold J.
Levine Board Member Peter Neupert Board Member Andris Zoltners Board Member
Chad Robins Chief Executive Officer & Co-Founder Tom Willis, PhD Board Member
ADVISORS ADVISORSJay Shendure, MD, PHD Professor, Genome Sciences, University
of Washington Gerald T. Nepom, MD, PHD Director, Benaroya Research Institute
at Virginia Mason, Seattle; and Professor (Affiliate), Department of
Immunology, University of Washington School of Medicine Edus Houston Warren,
MD, PHD Associate Professor, University of Washington; and Associate Member,
Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer
Research Center David Miklos, MD, PHD Associate Professor (Blood and Marrow
Transplantation), Stanford University Medical Center HEMATOLOGY BOARDFrederick
R. Appelbaum, MD Executive Vice President and Deputy Director, Fred Hutchinson
Cancer Research Center Marco Davila, MD, PHD Associate Professor, University
of South Florida; and Associate Member, Moffitt Cancer Center Rafael Fonseca,
MD, PHD Site Director, Hematological Malignancies, and Getz Family Professor
of Cancer Chair, Department of Medicine, Mayo Clinic Arizona; Distinguished
Mayo Investigator Paolo Ghia, MD, PHD Associate Professor, San Raffaele
University Scientific Coordinator of the Lymphoma Unit, Department of
Oncology, and principal investigator in the Laboratory of Lymphoid
Malignancies at the San Raffaele Scientific Institute; Chairman, Basic &
Translational Committee of the European Research Initiative on CLL (ERIC)
Member, The Advisory Board for the Scientific Programme Committee of the
European Hematology Association (EHA) Thomas S. Kupper, MD Thomas B.
Fitzpatrick Professor of Dermatology, Harvard Medical School, and Chairman of
Dermatology, Dermatologist in Chief Brigham and Women’s Hospital Dana Farber
Cancer Institute Richard A. Larson, MD Professor of Medicine, Section of
Hematology/Oncology Director of the Hematologic Malignancies Clinical Research
Program, and Chairman of The Leukemia Committee of The Cancer and Leukemia
Group B, University of Chicago Ching-Hon Pui, MD Chair of the Department of
Oncology at St. Jude Jerry Radich, MD Member of the Clinical Research Division
at the Fred Hutchinson Cancer Research Center; Professor of Medicine at the
University of Washington Andrew D. Zelenetz, MD, PHD Medical Director, Quality
Informatics, Memorial Sloan-Kettering Cancer Center IMMUNO-ONCOLOGY
BOARDRobert Anders, MD, PHD Associate Professor, Pathology, Johns Hopkins
University School of Medicine Mac Cheever, MD Director of Solid Tumor
Research, Fred Hutchinson Cancer Research Center, and Professor of
Medicine/Oncology, University of Washington F. Stephen Hodi, MD Director,
Center of Immuno-Oncology; and Sharon Crowley Martin Chair (Melanoma) Dana
Farber Cancer Institute, and Professor of Medicine, Harvard Medical School
Elizabeth Jaffee, MD Co-Director of the Division of Immunology, and Co-leader
of the Gastrointestinal Cancers Program in the Department of Oncology and the
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Associate
Director for Translational Research at the Sidney Kimmel Cancer Center at
Johns Hopkins Hiroyoshi Nishikawa, MD, PHD Director, Division of Cancer
Immunology, National Cancer Center East Japan Eric Pamer, MD Chief of the
Infectious Diseases Service at Memorial Sloan-Kettering Cancer Center Stan
Riddell, MD Scientific Director, Immunotherapy Integrated Research Center,
Fred Hutchinson Cancer Research Center; and Professor of Oncology, University
of Washington School of Medicine Ton Schumacher, PHD Group Leader, The
Netherlands Cancer Institute Mario Sznol, MD Professor of Medicine (Medical
Oncology), and Clinical Research Program Leader, Melanoma Program, Yale Cancer
Center; Co-Director, Yale SPORE in Skin Cancer Pierre Van Der Bruggen, PHD
Member, Ludwig Institute for Cancer Research in Brussels Jedd Wolchok, MD, PHD
Chief, Melanoma and Immunotherapeutics Service at Memorial Sloan Kettering
Cancer Center; Associate Director, Ludwig Center for Cancer Immunotherapy at
MSKCC Cassian Yee, MD Professor at the MD Anderson Cancer Center, University
of Texas Keep up to date with Adaptive. Join our newsletter.
Corporate/Research (855) 466-8667 Diagnostics (888) 522-8988 Immune Profiling
PlatformPlatform Overview Publications Products & ServicesLIFE SCIENCES
RESEARCH immunoSEQ® CLINICAL DIAGNOSTICS clonoSEQ® Pipeline DRUG DISCOVERY
Cellular Therapy Vaccines PartnershipsCancer Cellular Therapy Antigen Map
Biopharma Partnerships Strategic Collaborators About UsOur Story Culture
Careers News & Events Contact Us © Adaptive Biotechnologies. All Rights
Reserved. Terms of Use Online Privacy Policy Privacy Shield Policy HIPAA
Policy Code of Conduct Patents & Trademarks Licenses Join the Adaptive
newsletter Get news from Adaptive Biotech in your inbox. Email *First Name
Last Name Company Country * Yes, I would like to receive emails from Adaptive
Biotech. (You can unsubscribe anytime)Constant Contact Use.By submitting this
form, you are consenting to receive marketing emails from: Adaptive
Biotechnologies, 1551 Eastlake Avenue E., Suite 200, Seattle, WA, 98102. You
can revoke your consent to receive emails at any time by using the
SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced
by Constant Contact